Sales don't justify the share price?
Says the guy saying "buy Mxx" when it was valued at $2b and not only no revenue on horizon, but no FDA approval, no proven product.
And I trust the surgeons I speak to. I definitely trust them over Bell potter or your neighbours who are all "medicos".
And I say the shorts are sweating because they know what happened this time last year. They sweated hard then.
Anyways, go back and worry about Novartis.
Short Activity in PNV, page-1247
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.005(0.19%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.61 | $2.57 | $906.5K | 350.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 39743 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 18499 | 32 |
View Market Depth
| Last trade - 13.52pm 20/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |